REBECCA FLANNELLY: Open Payments
NPI 1225881832 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 29 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $73 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| CeQur Corporation | 1 | $54 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Lundbeck LLC | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: VERQUVO, REXULTI, Kerendia, CeQur Simplicity, Auvelity, GEMTESA, CAPLYTA, QULIPTA.
Industry payments across TN — which companies pay providers there.
